Transcriptional Control of Cytokine Genes

References

• Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Miyajima A., Hara T., Kitamura T. Common subunits of cytokine receptors: a basis for the functional redundancy of multiple cytokines. Trends Biochem. Sciences 1992; 17: 378–382
   PubMed Web of Science ®Google Scholar
• Lopez A. F., Eglinton J. M., Lyons A. B., Tapley P. M., To L. B., Park L. S., Clarke S. C., Vadas M. A. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity. J. Cell. Physiol. 1990; 145: 69–77
   PubMed Web of Science ®Google Scholar
• Kitamura T., Sato N., Arai K., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165–1174
   PubMed Web of Science ®Google Scholar
• Watowich S. S., Hilton D. J., Lodish H. F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell Biol. 1994; 14: 3535–3549
   PubMed Web of Science ®Google Scholar
• Alexander W. S., Metcalf D., Dunn A. R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 1995; 14: 5569–5578
   PubMed Web of Science ®Google Scholar
• Takaki S., Murata Y., Kitamura T., Miyajima A., Tominaga A., Takatsu K. Reconstitution of the functional receptors for murine and human interleukin-5. J. Exp. Med. 1993; 177: 1523–1529
   PubMed Web of Science ®Google Scholar
• Sakamaki K., Miyajima I., Kitamura T., Miyajima A. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 1992; 11: 3541–3549
   PubMed Web of Science ®Google Scholar
• Muto A., Watanabe S., Itoh T., Miyajima A., Yokota T., Arai K. Roles of the cytoplasmic domains of the alpha and beta subunits of human granulocyte-macrophage colony-stimulating factor receptor. J. Allergy Clin. Immunol. 1995; 96: 1100–1114
   PubMedGoogle Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFNβ2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573–581
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Russell S. M., Mess S. A., Friedmann M., Erdos M., Francois C., Jacques Y., Adelstein S., Leonard W. J. Heterodimerization of the IL-2 receptor b- and g-chain cytoplasmic domains is required for signalling. Nature 1994; 369: 330–333
   PubMed Web of Science ®Google Scholar
• Caput D., Laurent P., Kaghad M., Lelias J. M., Lefort S., Vita N., Ferrara P. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 1996; 271: 16921–16926
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Zhang J. G., Metcalf D., Alexander W. S., Nicola N. A., Willson T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 1996; 93: 497–501
   PubMed Web of Science ®Google Scholar
• Mui A. L.-F., Wakao H., O'Farrell A., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995; 14: 1166–1175
   PubMed Web of Science ®Google Scholar
• Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995; 268: 251–255
   PubMed Web of Science ®Google Scholar
• Ihle J. N. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331–334
   PubMed Web of Science ®Google Scholar
• Schindler C., Darnell J., Jr. Transcriptional respones to polypeptide ligands; the JAK-STAT pathway. Annu. Rev. Biochem. 1995; 64: 621–651
   PubMed Web of Science ®Google Scholar
• Zhang X., Blenis J., Li H. C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995; 267: 1990–1994
   PubMedGoogle Scholar
• Wen Z., Zhong Z., Darnell J. E., Jr. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosin and serine phoshorylation. Cell 1995; 82: 241–250
   PubMed Web of Science ®Google Scholar
• Beadling C., Babbage J. W., Cantrell D. A. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2/MAPkinase pathway. EMBO J. 1996; 15: 1902–1913
   PubMedGoogle Scholar
• Bhat G. J., Thekkumkara T. J., Thomas W. G., Conrad K. M., Baker K. M. Activation of the STAT pathway by angiotensin II in T3CHO/AT1A cells. Crosstalk between angiotensin II and interleukin-6 nuclear signaling. J. Biol. Chem. 1995; 270: 19059–19065
   PubMed Web of Science ®Google Scholar
• Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., Bernstein K. E. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995; 375: 247–250
   PubMed Web of Science ®Google Scholar
• Nosaka T., vanDeursen J. M., Tripp R. A., Thierfelder W. E., Witthuhn B. A., McMickle A. P., Doherty P. C., Grosveld G. C., Ihle J. M. Defective lymphoid development in mice lacking Jak3. Science 1995; 270: 800–802
   PubMed Web of Science ®Google Scholar
• Park S. Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., Miyake K., Nakauchi H., Shirasawa T., Saito T. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995; 3: 771–782
   PubMed Web of Science ®Google Scholar
• Thomis D. C., Gurniak C. B., Tivol E., Sharpe A. I., Berg L. J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995; 270: 794–797
   PubMed Web of Science ®Google Scholar
• Murata T., Noguchi P. D., Puri R. K. Receptors for Interleukin (IL)-4 do not associate with the common g chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 1996; 270: 30829–30836
   Google Scholar
• Heim M. H., Kerr I. M., Stark G. R., Darnell J. E.J. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 1995; 267: 1347–1349
   PubMed Web of Science ®Google Scholar
• Hemmann U., Gerhartz C., Heesel B., Sasse J., Kurapkat G., Grotzinger J., Wollmer A., Zhong Z., Darnell J. E. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp 130. II. Src homology SH2 domains define the specificity of Stat factor activation. J. Biol. Chem. 1996; 271: 12999–13007
   PubMed Web of Science ®Google Scholar
• Leung S., Qureshi S. A., Kerr I. M., Darnell J. E.J., Stark G. R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 1995; 15: 1312–13175
   PubMedGoogle Scholar
• Bacon C. M., McVicar D. W., Ortaldo J. R., Rees R. C., O'Shea J. J., Johnston J. A. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 1995; 181: 399–404
   PubMed Web of Science ®Google Scholar
• Jacobson N. G., Szabo S. J., Weber-Nordt R. M., Zhong Z., Schreiber R. D., Darnell J. E.J, Murphy K. M. Interleukin 12 signaling in T helper type 1 (Th 1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription Stat3 and Stat4. J. Exp. Med. 1995; 181: 1755–1762
   PubMed Web of Science ®Google Scholar
• Shimoda K., vanDeursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A., Chu C., Quelle F. W., Nosaka T., Vignali D. A., Doherty P. C., Grosveld G., Paul W. E., Ihle J. N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630–633
   PubMed Web of Science ®Google Scholar
• Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 627–630
   PubMed Web of Science ®Google Scholar
• Thiefelder W. E., vanDeursen J. M., Yamamoto T., Tripp R. A., Sarawar S. R., Carson R. T., Samgster M. Y., Vignali D. A., Doherty P. C., Grosveld G. C., Ihle J. N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382: 171–174
   PubMedGoogle Scholar
• Kaplan M. H., Sun Y. L., Hoey T., Gruby M. J. Impaired IL-12 responses and enhanced development of Th 2 cells in Stat4 deficient mice. Nature 1996; 382: 174–177
   PubMed Web of Science ®Google Scholar
• deKoning J. P., Dong F., Smith L., Schelen A. M., Barge R. M., van der Plas D. C., Hoefsloot L. H., Lowenberg B., Touw I. P. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 1996; 87: 1335–1342
   PubMed Web of Science ®Google Scholar
• Minami M., Inoue M., Wei S., Takeda K., Matsumoto M., Kishimoto T., Akira S. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloidcell line. Proc. Natl. Acad. Sci. USA 1996; 93: 3963–3966
   PubMed Web of Science ®Google Scholar
• Mui A. L.F., Wakao H., Kinoshita T., Kitamura T., Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 1996; 15: 2425–2433
   PubMed Web of Science ®Google Scholar
• Friedmann M. C., Migone T., Russell S. M., Leonard W. J. Different interleukin 2 receptor b-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 1996; 93: 2077–2082
   PubMed Web of Science ®Google Scholar
• Damen J. E., Wakao H., Miyajima A., Krosl J., Humphries R. K., Cutler R. L., Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. Embo J. 1995; 14: 5557–68
   PubMed Web of Science ®Google Scholar
• Fujii H., Nakagawa Y., Schindler U., Kawahara A., Mori H., Gouilleux F., Groner B., Ihle J. N., Minami Y., Miyazaki T., Taniguchui T. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 1995; 92: 5482–5486
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Wang D., Nosaka T., Thierfelder W. E., Stravopodis D., Weinstein Y., Ihle J. N. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 1996; 16: 1622–1631
   PubMed Web of Science ®Google Scholar
• Meraz M. A., White J. M., Sheehan K. C., Back E. A., Rodig S. J., Dighe A. S., Kaplan D. H., Riley J. K., GreenIund A. C., Campbell D., Carver-Moore K., DuBois R. N., Clark R., Aguet M., Schreiber R. D. Targeted disruption of the Stat1 gene in mice reveals unexprected physiologic specificity in the JAK–STAT signaling pathway. Cell 1996; 84: 431–442
   PubMed Web of Science ®Google Scholar
• Watanabe S., Itoh T., Arai K. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem. 1996; 271: 12681–12686
   PubMed Web of Science ®Google Scholar
• Bignon J. S., Siminovitch K. A. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoeitic cell differentiation and function. Clin. Immuno. Immunopath. 1994; 73: 168–179
   PubMedGoogle Scholar
• Klingmuller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 1995; 80: 726–738
   Google Scholar
• Chu Y., Solski P. A., Khosravi-Far R., Der C. J., Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 1996; 271: 6497–6591
   PubMed Web of Science ®Google Scholar
• Kim T. K., Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 1996; 273: 1717–1719
   PubMed Web of Science ®Google Scholar
• Bourette R. P., Mouchiroud G., Ouazana R. Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine plulipotent hematopoietic NSF60 cells induces long-term proliferation in response to CSF-1 without loss of erythroid differentiation potiential. Blood 1993; 81: 2511–2520
   PubMedGoogle Scholar
• Yoshikawa A., Murakami H., Nagata S. Distinct signal transduction through the tyrosine-containing domains of the granulocyte-colony simulating factor receptor. EMBO J. 1995; 14: 5288–5296
   PubMed Web of Science ®Google Scholar